Skip to main content
Premium Trial:

Request an Annual Quote

Adam Sachs, David Weber

Premium
Lentigen has named Adam Sachs to the newly created position of president of commercial operations, where he will lead efforts to market the firm’s lentiviral platform, the company said.
 
Sachs comes to Lentigen having spent 15 years in the biotech field, most recently as a molecular biology product development executive at Life Technologies, which is now Invitrogen.
 
Sachs also was director of manufacturing at Qiagen and vice president of operations at OriGene Technologies.
 

 
The Analytical and Life Science Systems Association, a trade group for product makers and marketers in the life sciences, has appointed Eksigent president and CEO David Weber to its board of directors, Eksigent said.
 
Before joining Eksigent Weber served as vice president of global marketing and business development for Stratagene and was president of the Americas at Amersham Biosciences.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.